CYCLERION THERAPEUTICS INC (CYCN) Forecast, Price Target & Analyst Ratings

NASDAQ:CYCNUS23255M2044

Current stock price

1.505 USD
-0.05 (-2.9%)
At close:
1.47 USD
-0.03 (-2.33%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CYCLERION THERAPEUTICS INC (CYCN).

Forecast Snapshot

Consensus Price Target

Price Target
$8.16
+ 442.19% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 4, 2026
Period
Q4 / 2025
EPS Estimate
-$0.39
Revenue Estimate
102K

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$8.16
Upside
+ 442.19%
From current price of $1.51 to mean target of $8.16, Based on 7 analyst forecasts
Low
$8.08
Median
$8.16
High
$8.40

Price Target Revisions

1 Month
100.00%
3 Months
100.00%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for CYCN. The average price target is 8.16 USD. This implies a price increase of 442.19% is expected in the next year compared to the current price of 1.505.
The average price target has been revised upward by 100% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

CYCN Current Analyst RatingCYCN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

CYCN Historical Analyst RatingsCYCN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
CYCN was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CYCN.
In the previous month the buy percentage consensus was at a similar level.
CYCN was analyzed by 7 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2021-10-20Truist SecuritiesInitiate Buy
2021-09-24Cantor FitzgeraldInitiate Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 4, 2026
Period
Q4 / 2025
EPS Estimate
-$0.39
Revenue Estimate
102K
Revenue Q2Q
-94.35%
EPS Q2Q
N/A
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
N/A

Next Earnings Summary

CYCN is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is -0.39 USD and the consensus revenue estimate is 102.00K USD.

Full Analyst Estimates 2025 - 2027

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
CYCN revenue by date.CYCN revenue by date.
1.63M
-58.63%

-100.00%
2M1.122M
-43.90%

-100.00%
EBITDA
YoY % growth
CYCN ebitda by date.CYCN ebitda by date.
-44.3M
17.72%
-9.647M
78.22%
N/AN/AN/AN/A
EBIT
YoY % growth
CYCN ebit by date.CYCN ebit by date.
-44.37M
18.30%
-9.647M
78.26%
-3.628M
62.39%
-5.916M
-63.07%
-13.26M
-124.14%
-16.116M
-21.54%
Operating Margin
CYCN operating margin by date.CYCN operating margin by date.
-2,722.09%N/A-181.40%-527.27%N/AN/A
EPS
YoY % growth
CYCN eps by date.CYCN eps by date.
N/A
96.01%
N/A
-19.09%
N/A-1.37-0.92
32.84%
-0.84
8.89%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25
EPS
Q2Q % growth
-0.39
Revenue
Q2Q % growth
102K
-94.35%
EBITDA
Q2Q % growth
N/A
EBIT
Q2Q % growth
-1.632M
-425.10%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CYCN Yearly Revenue VS EstimatesCYCN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2024 2025 1M 2M 3M 4M
CYCN Yearly EPS VS EstimatesCYCN Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2025 2026 2027 -20 -40 -60 -80 -100

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
9.45%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-25.99%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

CYCLERION THERAPEUTICS INC / CYCN Forecast FAQ

What is the average price target for CYCLERION THERAPEUTICS INC (CYCN) stock?

7 analysts have analysed CYCN and the average price target is 8.16 USD. This implies a price increase of 442.19% is expected in the next year compared to the current price of 1.505.

Can you provide the upcoming earnings date for CYCLERION THERAPEUTICS INC?

CYCLERION THERAPEUTICS INC (CYCN) will report earnings on 2026-05-04.

What are the consensus estimates for CYCLERION THERAPEUTICS INC (CYCN) next earnings?

The consensus EPS estimate for the next earnings of CYCLERION THERAPEUTICS INC (CYCN) is -0.39 USD and the consensus revenue estimate is 102.00K USD.

What is the consensus rating for CYCN stock?

The consensus rating for CYCLERION THERAPEUTICS INC (CYCN) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.